Leyden Laboratories Bv

02/27/2025 | Press release | Archived content

Leyden Labs Appoints Clarissa Koch, PhD to Chief Research Officer

Following exciting advancements with new investments, scientific successes with our Mucosal Protection Platform, and clinical progress in our pipeline, we are happy to announce that we are further strengthening our senior leadership team.

We are pleased to announce the appointment of Clarissa Koch to Chief Research Officer, expanding her role to lead all Research functions at Leyden Labs. Clarissa has spearheaded Leyden Labs' Mucosal Protection Platform.

Jaap Goudsmit, co-founder of Leyden Labs, will now serve as Chief Scientist, advising on the company's scientific strategy.

Leyden Laboratories Bv published this content on February 27, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 28, 2026 at 19:24 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]